Genmab — December 2024
-
To learn more about the innovaTV 301 trial and its impact on cervical cancer treatment, watch the video https://www.primrmed.com/cancer-education/the-innovatv-301-trial-for-patients-with-cervical-cancer https://www.primrmed.com/blog-post/breakthrough-treatment-for-metastatic-cervical-cancer-the-innovatv-301-trial
-
our old "friend" morphosys - Novartis says 330 jobs hit as it closes MorphoSys sites https://www.reuters.com/business/healthcare-pharmaceuticals/some-330-jobs-hit-novartis-closes-morphosys-wiwo-reports-2024-12-19/?taid=6763f5afdd611200016084a9&utm_campaign=trueanthem&utm_medium=trueanthem&utm_source=twitter
-
small new Ph2
trial - Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma https://clinicaltrials.gov/study/NCT06575686 -
Genmab får hævet anbefaling til "market perform" af Bernstein https://proinvestor.com/investornyt/1256245/genmab-far-haevet-anbefaling-til-market-perform-af-bernstein
-
Japanese GEN1042 trial adds 2 arms , but i can not immediately see the difference between cohorts 1&2 and 3&4... https://clinicaltrials.gov/study/NCT06057038?tab=history&a=13&b=14&compareMode=sideBySide#version-content-panel
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
